Claude Mythos 5 for Product Managers: Anthropic's Most Capable Model
TL;DR
Claude Mythos 5 is Anthropic's most capable model and the only one without safety classifiers. It is not publicly available. Access requires approval through Project Glasswing, Anthropic's restricted partner program for cybersecurity research, drug discovery, and advanced scientific work. Pricing is $10/$50 per million tokens, the same as Fable 5. For most product teams, Fable 5 or Opus 5 is the right choice. This article explains who Mythos 5 is actually for, what it can do that other Claude models cannot, and the narrow set of product use cases where requesting access is worth it.
The AI PM Minute
One tactic to make you a sharper AI PM, twice a week. 60 seconds to read. Free.
No fluff. Unsubscribe anytime.
What Claude Mythos 5 Is and How It Differs
Anthropic released Claude Fable 5 and Claude Mythos 5 together in June 2026. Both are Mythos-class models sharing identical technical specs: a 1 million token context window, a 128,000 token output limit, and $10 per million input tokens and $50 per million output tokens. On benchmarks, they perform within a fraction of a percent of each other across nearly every measured capability.
The meaningful difference is not capability. It is access and safety architecture.
Fable 5 ships with a classifier layer that intercepts a specific set of high-risk requests: cybersecurity offensive capabilities, biological and chemical synthesis routes for dangerous substances, and model distillation attempts. When the classifier fires, the request is routed to Claude Opus 4.8 instead, which is trained to decline those categories. This triggers on fewer than 5% of sessions. Fable 5 is generally available through the Anthropic API and AWS.
Mythos 5 does not include these classifiers. It can engage directly with requests that Fable 5 routes away. That is the entire architectural difference, and it is also why the model exists: for specialized research contexts where those classifier interventions would block legitimate, authorized work.
Fable 5
Generally available via API and AWS. Safety classifiers active. Routes dangerous biology, chemistry, cybersecurity offense, and distillation requests to Opus 4.8. Right choice for 99% of product teams.
Mythos 5
Restricted to Project Glasswing partners. No safety classifiers. Full capability exposed. Right choice for approved research labs, security teams, and scientific discovery programs.
Opus 5
Generally available. $5/$25 per million tokens. Performs within 0.5% of Fable 5 on most tasks. Supports Fast Mode at 2.5x normal output speed. Right choice when cost matters and Mythos-class quality is not required.
Sonnet 5
Generally available. Introductory pricing $2/$10 through August 31, 2026, then $3/$15. Close to Opus 4.8 performance at significantly lower cost. Right for high-volume production inference.
Project Glasswing: Who Can Access It and How
Project Glasswing is Anthropic's controlled access program for Mythos 5. It is not a waitlist. It is a structured partner approval process designed to ensure the model is used in contexts with meaningful institutional oversight, clear legitimate purpose, and audit capabilities.
Anthropic describes the eligible categories as cybersecurity research and offensive capability analysis, pharmaceutical and drug design programs, materials science and scientific discovery pipelines, and advanced AI safety research. Approved partners are required to document their use cases, maintain usage logs, and agree to usage policies that are stricter than the standard API terms.
Likely to be approved
Academic research institutions with IRB oversight, pharmaceutical companies running drug discovery programs, cybersecurity firms conducting authorized penetration testing, government research labs with established compliance frameworks.
Unlikely to be approved
General-purpose AI product startups, SaaS companies without regulated-industry verticals, individual researchers without institutional affiliation, teams that cannot demonstrate meaningful audit and oversight infrastructure.
The right question to ask first
Can your use case be accomplished with Fable 5? The classifier interventions target a narrow set of requests. If you are not specifically blocked by them in Fable 5, you do not need Mythos 5.
Anthropic has not published a public application link for Project Glasswing as of August 2026. Access requests go through enterprise sales and require a qualified use-case description. Expect a review process of four to eight weeks and legal review of the partnership agreement.
Benchmark Profile: Where Mythos 5 Is Strongest
Mythos 5 and Fable 5 share the same benchmark results on standard evaluations. Neither model meaningfully outperforms the other on MMLU, HumanEval, or general reasoning tasks. The capability gap shows up in specialized domains and at the boundary of what frontier models can currently do.
Anthropic describes Mythos 5 as holding the strongest cybersecurity capabilities of any currently available model. Independent security researchers who participated in the early access program have described its ability to reason through novel vulnerability classes and multi-step attack chains as qualitatively different from any publicly available model, including Fable 5 with the classifier layer removed.
Cybersecurity and Vulnerability Research
What it does: Novel attack chain analysis, zero-day vulnerability reasoning, exploit development for authorized penetration testing, and security control gap analysis.
PM implication: For product security teams at well-funded enterprises, this is the first model capable of meaningful offensive security research at scale. If you are building security products for enterprise buyers who run their own red teams, this becomes relevant.
Pharmaceutical and Drug Discovery
What it does: Protein structure reasoning, drug-target interaction prediction, synthesis pathway generation, and ADMET property analysis for candidate compounds.
PM implication: Biotech and pharma product teams building AI-assisted discovery pipelines should evaluate Mythos 5 directly. Early Glasswing partners report it closing significant gaps in the synthesis reasoning tasks where Fable 5 returns refusals.
Advanced Scientific Research
What it does: Long-document scientific synthesis (using the full 1M context window), cross-disciplinary hypothesis generation, and mathematical proof assistance at the frontier of current research.
PM implication: Scientific publishing platforms, research tooling for academia, and knowledge management systems for R&D-intensive industries are the relevant product categories.
Build Real AI Product Skills in the Masterclass
The AI PM Masterclass covers model evaluation, vendor strategy, and how to build a roadmap around a fast-moving model landscape. Taught live by a Salesforce Sr. Director PM.
How Mythos 5 Fits in the Claude Model Stack
Anthropic's model lineup in mid-2026 has four effective tiers for API users. Understanding where each sits helps product managers make model selection decisions that hold up across a fast-moving landscape.
Mythos 5
$10/$50 per MtokAccess: Restricted (Project Glasswing)
Authorized scientific research, offensive security, drug discovery pipelines with institutional oversight
Fable 5
$10/$50 per MtokAccess: Generally available
Complex long-horizon tasks, autonomous agents, high-stakes knowledge work, enterprise flagship use cases
Opus 5
$5/$25 per MtokAccess: Generally available
Enterprise-grade reasoning at half the Fable/Mythos price, supports Fast Mode for latency-sensitive applications
Sonnet 5
$2/$10 (intro) / $3/$15 per MtokAccess: Generally available (default for Free and Pro)
Production inference at scale, everyday coding, document analysis, cost-optimized AI product features
Haiku 4.5
$1/$5 per MtokAccess: Generally available
High-volume classification, extraction, summarization tasks where cost is the primary constraint
The cost parity between Mythos 5 and Fable 5 is worth noting. Anthropic is not using price to gate access. If you have Project Glasswing approval, you pay the same rate as a team running Fable 5. The gatekeeping mechanism is institutional, not economic.
Product Use Cases Where Mythos 5 Changes What Is Possible
Most AI product teams will never need Mythos 5. That is not a judgment on the quality of their products. It reflects the reality that the classifier interventions in Fable 5 are narrow and most product use cases do not approach them.
The use cases where Mythos 5 is genuinely irreplaceable share three characteristics: the required output sits in a category that Fable 5 routes away, the team has institutional authorization to work in that category, and the economic value of access is large enough to justify the Glasswing approval process.
Security research platforms
Products that help corporate red teams and security researchers analyze offensive techniques. The Glasswing use case: full vulnerability reasoning without classifier interventions that stop analysis at the critical step.
Pharmaceutical AI pipelines
Drug discovery products where synthesis pathway generation is core functionality. Fable 5 declines some synthesis route requests. Mythos 5 does not. Bayer, in early Glasswing, uses the model for hypothesis generation across 10,000 scientific papers.
AI safety research tooling
Teams building interpretability tools, alignment research platforms, or evaluation frameworks for frontier models. Studying model behavior at the capability boundary requires full access to that capability.
Government and defense contractors
Authorized teams working in national security or defense research contexts where full model capability is required and institutional oversight structures are already in place.
The Decision Framework: Do You Actually Need It?
Before pursuing a Project Glasswing application, work through these four questions. Most teams will get a clear "no" before reaching question four, which will save months of internal approvals and legal review.
Q1: Does your use case hit Fable 5 classifiers?
Run your representative prompts against Fable 5. If they succeed, you do not need Mythos 5. The classifiers are narrow. Most legitimate cybersecurity, pharma, and research work does not trigger them.
Q2: Do you have institutional authorization for this category of work?
Anthropic is not going to approve a two-person startup to access offensive cybersecurity capabilities. If your team does not have the compliance infrastructure, IRB oversight, or institutional affiliation that matches your use case, the application will not succeed.
Q3: Can you build the audit and oversight infrastructure Anthropic requires?
Glasswing partners commit to usage logging, periodic review, and stricter contractual terms. Factor the compliance overhead into your evaluation of whether this is worth pursuing.
Q4: Is the economic value large enough to justify the process?
If your product generates tens of millions in revenue from the affected use case, the approval process is worth it. If the affected use case is a secondary feature, consider whether a narrower solution is more pragmatic.
For the small number of teams that pass all four checks: the path to access is through Anthropic enterprise sales, not through a public API application. Document your use case clearly, lead with your institutional context, and plan for a legal review of the partnership agreement.
For everyone else: Fable 5 and Opus 5 are excellent choices that cover the full frontier capability range without the access constraints. The arrival of Mythos 5 is most relevant as a signal about where Anthropic is investing at the technical frontier, and as evidence that the model capability ceiling continues to move significantly with each generation.
Master the AI Model Landscape
The AI PM Masterclass covers model selection strategy, vendor evaluation, and how to build products that stay competitive as the frontier shifts. Learn to make these decisions with confidence.
Related Articles
Before you go: get the AI PM Minute
One tactic to make you a sharper AI PM, twice a week. 60 seconds to read. Free.
No fluff. Unsubscribe anytime.